Abstracts tagged "CPPD"

Abstract Number: 1584 • ACR Convergence 2022
Colchicine or Prednisone for the Treatment of Acute Calcium Pyrophosphate Deposition Arthritis: A Multicenter Randomized Controlled Trial
Tristan Pascart¹, Pierre Robinet², Sebastien Ottaviani³, Remi Leroy⁴, Nicolas Segaud⁵, Aurore Pacaud², Hélène Luraschi², Thibault Rabin², Agathe Grandjean², Xavier Deplanque⁶, Pierre Maciejasz⁶, Fabien Visade², Alexandre Mackowiak², Nicolas Baclet⁶, Antoine Lefebvre², Jean-François Budzik², Thomas Bardin⁷, Pascal Richette⁸, Laurène Norberciak², Vincent Ducoulombier² and Eric Houvenagel¹, ¹Groupement Hospitalier de l'Institut Catholique de Lille, Lomme, France, ²Hôpital Saint-Philibert, Lomme, France, ³Hopital Bichat-Claude Bernard, Paris, France, ⁴Centre Hospitalier de Dunkerque, Dunkerque, France, ⁵Centre Hospitalier d'Armentières, Armentières, France, ⁶Hôpital Saint-Vincent-de-Paul, Lille, France, ⁷Hôpital Lariboisiere, Paris, France, ⁸Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France
Background/Purpose: Treatment of acute CPP arthritis mainly relies on expert opinion, as there are no trials that assessed the efficacy of anti-inflammatory drugs, despite the…
Abstract Number: 1790 • ACR Convergence 2022
Ultrasound Diagnosis of Calcium Pyrophosphate Crystal Deposition: Which Sites Should Be Scanned?
Edoardo Cipolletta¹, Erica Moscioni², Silvia Sirotti³, Georgios Filippou⁴ and Emilio Filippucci⁵, ¹Polytechnic University of Marche, Ancona, Italy, ²Polytechnic University of Marche, Jesi, Italy, ³Università degli Studi di Milano, Milano, Italy, ⁴Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy, ⁵Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Italy
Background/Purpose: In recent years, ultrasonography (US) has emerged as an accurate and reliable tool for the diagnosis of calcium pyrophosphate (CPP) deposition disease (CPPD) in…
Abstract Number: 1791 • ACR Convergence 2022
Point-of-Care Multi-Energy Photon-Counting CT for Earlier Non-Invasive Diagnosis of Gout and Calcium Pyrophosphate Deposition Disease
Fabio Becce¹, Anais Viry², Damien Racine², David Rotzinger¹, Tristan Pascart³, Georgios Filippou⁴, Jérôme Damet² and Lucia Gallego Manzano², ¹Lausanne University Hospital (CHUV), Lausanne, Switzerland, ²Institute of Radiation Physics, Lausanne, Switzerland, ³Groupement Hospitalier de l'Institut Catholique de Lille, Lomme, France, ⁴Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: While the definitive diagnosis of gout and calcium pyrophosphate deposition disease (CPPD) is still based on the identification of characteristic crystals in synovial fluid…
Abstract Number: 1795 • ACR Convergence 2022
Therapeutic Strategies for Patients with Chronic Manifestations of Calcium Pyrophosphate Deposition Disease
Julien Damart¹, Silvia Sirotti², Mariano Andrès³, Edoardo Cipolletta⁴, Georgios Filippou⁵, Davide Carboni⁶, Emilio Filippucci⁷, Pilar Diez⁸, Abhishek Abhishek⁹, Augustin Latourte¹⁰, Hang-Korng Ea¹¹, Sebastien Ottaviani¹², Jean-Guillaume Letarouilly¹³, Renaud Desbarbieux¹⁴, Sahara Graf¹, Laurène Norberciak¹, Pascal Richette¹⁵ and Tristan Pascart¹⁶, ¹Hôpital Saint-Philibert, Lomme, France, ²Università degli Studi di Milano, Milano, Italy, ³Dr Balmis Alicante General University Hospital-ISABIAL, Alicante, Spain, ⁴Polytechnic University of Marche, Ancona, Italy, ⁵Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy, ⁶Luigi Sacco University, Milano, Italy, ⁷Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Italy, ⁸Alicante University, Alicante, Spain, ⁹University of Nottingham, Nottingham, United Kingdom, ¹⁰Université de Paris, Paris, France, ¹¹Lariboisière Hospital, Paris, France, ¹²Hopital Bichat-Claude Bernard, Paris, France, ¹³CHU Lille, Lille, France, ¹⁴Ch Boulogne-sur-Mer, Boulogne-sur-Mer, France, ¹⁵Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, ¹⁶Groupement Hospitalier de l'Institut Catholique de Lille, Lomme, France
Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease lacks recommendations on treatment strategies. This study reports on treatment modalities used in European tertiary hospitals for the management…
Abstract Number: 1813 • ACR Convergence 2022
Patient-Reported Outcomes in CPPD Compared to Gout and Osteoarthritis
Mary Grace Whelan¹, Keigo Hayashi² and Sara Tedeschi¹, ¹Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Okayama, Japan
Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease prevalence is similar to gout and osteoarthritis (OA), yet CPPD outcomes research greatly lags behind these other forms of…
Abstract Number: 1817 • ACR Convergence 2022
Acute Coronary Syndrome in Calcium Pyrophosphate Deposition Disease Patients: A Cross-sectional Study from the National Inpatient Sample
Konstantinos Parperis¹ and Bikash Bhattarai², ¹University of Cyprus Medical School, Nicosia, Cyprus, ²Valleywise Health, Phoenix, AZ
Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) is a common crystal-induced arthritis characterized by the deposition of calcium pyrophosphate crystals in the articular tissues. Acute CPP…
Abstract Number: 1819 • ACR Convergence 2022
Calcium Pyrophosphate Deposition Disease Is Associated with an Increased Prevalence of Nephrolithiasis
Alison Fernandes¹, Yiran Jiang², Katherine Sherman³, Ikechukwu Mbonu², Rebecca Weiner² and Ann Rosenthal², ¹Medical College of Wisconsin, Oconomowoc, WI, ²Medical College of Wisconsin, Milwaukee, WI, ³Zablocki VA Medical Center, Milwaukee, WI
Background/Purpose: Calcium pyrophosphate deposition disease (CPDD) is a crystal arthropathy caused by calcium pyrophosphate (CPP) crystals. Individuals with CPDD also have increased risks for other…
Abstract Number: 1825 • ACR Convergence 2022
Vascular Calcifications Adjacent to the Involved Joint of Patients Diagnosed with Calcium Pyrophosphate Crystal Arthritis – a Retrospective Observational Study
Shay Brikman¹, Amir Bieber² and Reuven Mader¹, ¹Rheumatic Diseases Unit, Emek Medical Center, Afula, Israel, ²Emek Medical Center, Raanana, Israel
Background/Purpose: Prior studies have shown an association between chondrocalcinosis (CC) and vascular calcifications. In this study, we aimed to assess the presence of vascular calcifications…
Abstract Number: 1913 • ACR Convergence 2022
The Association of Radiographic Chondrocalcinosis with Localized Structural Outcomes in Knee OA: The Multicenter Osteoarthritis Study
Jean Liew¹, Ali Guermazi², Mohamed Jarraya³, Na Wang¹, David Felson², Cora E. Lewis⁴, Michael Nevitt⁵, James Torner⁶, John A. Lynch⁷ and Tuhina Neogi¹, ¹Boston University School of Medicine, Boston, MA, ²Boston University, Boston, MA, ³Massachusetts General Hospital, Boston, MA, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵University of California at San Francisco, Orinda, CA, ⁶University of Iowa, Iowa City, IA, ⁷UCSF, San Francisco, CA
Background/Purpose: Intra-articular (IA) mineralization due to calcium crystal deposition may contribute to OA pathology through inflammation, release of pro-catabolic factors, or altered cartilage biomechanical properties.…
Abstract Number: 1582 • ACR Convergence 2021
Diagnostic Accuracy and Reliability of Conventional Radiography of the Knee in Calcium Pyrophosphate Deposition Disease by Using New Definitions: An Ancillary Study of the OMERACT Ultrasound – CPPD Group
Silvia Sirotti¹, Fabio Becce², Luca Maria Sconfienza³, Carlos Pineda⁴, Marwin Gutierrez⁵, Teodora Serban⁶, Daryl MacCarter⁷, Antonella Adinolfi⁸, Anna Scanu⁹, Carlo Alberto Scire¹⁰, Ingrid Moller¹¹, Esperanza Naredo¹², Piercarlo Sarzi-Puttini¹³, Abhishek Abhishek¹⁴, Hyon K. Choi¹⁵, Nicola Dalbeth¹⁶, Sara Tedeschi¹⁷, Maria-Antonietta D'Agostino¹⁸, Nemanja Damjanov¹⁹, Helen Keen²⁰, Lene Terslev²¹, Annamaria Iagnocco²² and Georgios Filippou²³, ¹Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, ²Lausanne University Hospital, Lausanne, Switzerland, ³Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy, ⁴Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, ⁵Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitacion, Mexico City, Mexico, ⁶Ospedale La Colletta, ASL3 Genovese, Genoa, Italy, ⁷Rheumatology Department, North Valley Hospital, Whitefish, MT, ⁸Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, ⁹Department of Medicine-DIMED, Rheumatology Unit, University of Padova, Padoa, Italy, ¹⁰SIR Epidemiology, Research Unit, Pavia, Italy, ¹¹University of Barcelona, Barcelona, Spain, ¹²Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, ¹³Rheumatology Department, Luigi Sacco University Hospital, Milano, Italy, ¹⁴University of Nottingham, Nottingham, United Kingdom, ¹⁵Massachusetts General Hospital, Lexington, MA, ¹⁶University of Auckland, Auckland, New Zealand, ¹⁷Brigham and Women's Hospital, Boston, MA, ¹⁸Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, ¹⁹University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, ²⁰University of Western Australia, Daglish, Australia, ²¹Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, ²²University of Turin, Roma, Italy, ²³Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: Conventional Radiography (CR) has been widely used in Calcium Pyrophosphate Deposition Disease (CPPD) and is considered an important tool for the diagnosis. However, there…
Abstract Number: 1583 • ACR Convergence 2021
Creation of an Ultrasonographic Scoring System for CPPD Extent: Results from a Delphi Process by the OMERACT US Working Group – CPPD Subgroup
Silvia Sirotti¹, Antonella Adinolfi², Fabio Becce³, Tomas Cazenave⁴, Sara Nysom Christiansen⁵, Edoardo Cipolletta⁶, Andrea Delle Sedie⁷, Mario Enrique Diaz Cortes⁸, Fabiana Figus⁹, Emilio Filippucci¹⁰, Peter Mandl¹¹, Daryl MacCarter¹², Ingrid Moller¹³, Mohamed Mortada¹⁴, Gael Mouterde¹⁵, Maria Esperanza Naredo Sanchez¹⁶, Carlos Pineda¹⁷, Francesco Porta¹⁸, Wolfgang Schmidt¹⁹, Teodora Serban²⁰, Lene Terslev²¹, Florentin Vreju²², Richard Wakefield²³, Pascal Zufferey²⁴, Piercarlo Sarzi-Puttini²⁵, Maria-Antonietta D'Agostino²⁶, Nemanja Damjanov²⁷, Annamaria Iagnocco²⁸, Helen Keen²⁹ and Georgios Filippou³⁰, ¹Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, ²Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, ³Lausanne University Hospital, Lausanne, Switzerland, ⁴Instituto de Rehabilitación Psicofisica, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁵Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, ⁶Polytechnic University of Marche, Jesi, Italy, ⁷University of Pisa, Pisa, Italy, ⁸Rheumatology Unit, University Hospital Fundación Santa Fe de Bogota, Bogotà, Colombia, ⁹University of Torino, Torino, Italy, ¹⁰Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Italy, ¹¹Medical University of Vienna, Vienna, Austria, ¹²Rheumatology Department, North Valley Hospital, Whitefish, MT, ¹³University of Barcelona, Barcelona, Spain, ¹⁴Zagazig University, Zagazig, Egypt, ¹⁵Rheumatology department, CHU Montpellier, Montpellier, France, ¹⁶Department of rheumatology, Joint and Bone research Unit, Hospital Universitario Fundación Jiménez díaz and Autónoma University, Madrid, Spain, ¹⁷Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, ¹⁸INS, Institute of Neurosciences, Florence, Italy, ¹⁹Immanuel Krankenhaus Berlin, Berlin, Germany, ²⁰ASL 3 Genovese, Genova, Italy, ²¹Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, ²²Rheumatology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania, ²³Rheumatology, Leeds University, Leeds, United Kingdom, ²⁴Rheumatology Department, University of Lausanne, CHUV, Lausanne, Switzerland, ²⁵L.Sacco University Hospital, Milano, Italy, ²⁶Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, ²⁷University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, ²⁸University of Turin, Roma, Italy, ²⁹University of Western Australia, Daglish, Australia, ³⁰Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: Ultrasound (US) has proven to be an excellent technique for detecting Calcium Pyrophosphate (CPP) deposits, however there are no grading systems that allow for…
Abstract Number: 1898 • ACR Convergence 2021
Risk of Major Adverse Cardiovascular Events in a Large Cohort of Patients with Acute Calcium Pyrophosphate Crystal Arthritis
Sara Tedeschi¹, Weixing Huang¹, Kazuki Yoshida¹ and Daniel Solomon², ¹Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Newton, MA
Background/Purpose: Acute calcium pyrophosphate (CPP) crystal arthritis, also known as pseudogout, causes an acute inflammatory arthritis that shares clinical similarities with gout. We investigated the…
Abstract Number: 0172 • ACR Convergence 2021
Assessing Relevant Joints for Monitoring CPPD Diseases: A Systematic Literature Review of Imaging Techniques by the OMERACT Ultrasound – CPPD Subgroup
Antonella Adinolfi¹, Silvia Sirotti², Garifallia Sakellariou³, Edoardo Cipolletta⁴, Emilio Filippucci⁵, Francesco Porta⁶, Piercarlo Sarzi-Puttini⁷, Carlo Alberto Scire⁸, Helen Keen⁹, Peter Mandl¹⁰, Carlos Pineda¹¹, Lene Terslev¹², Maria Antonietta D'Agostino¹³, Nemanja Damjanov¹⁴, Annamaria Iagnocco¹⁵ and Georgios Filippou¹⁶, ¹Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, ²Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, ³Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy, ⁴Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy, ⁵Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Italy, ⁶INS, Institute of Neurosciences, Florence, Italy, ⁷L.Sacco University Hospital, Milano, Italy, ⁸SIR Epidemiology, Research Unit, Pavia, Italy, ⁹University of Western Australia, Daglish, Australia, ¹⁰Medical University of Vienna, Vienna, Austria, ¹¹Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, ¹²Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, ¹³Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, ¹⁴University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, ¹⁵University of Turin, Roma, Italy, ¹⁶Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: Imaging has been extensively used for the diagnosis of Calcium Pyrophosphate Deposition Disease (CPPD) but the exact prevalence of joint calcifications at imaging in…
Abstract Number: 0670 • ACR Convergence 2021
Hemochromatosis Is Associated with CPPD Through Iron’s Effect on Bone
Jennifer Velasco, Claudia Gohr, Elizabeth MItton-Fitzgerald and Ann Rosenthal, Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Hemochromatosis (HH) is one of the strongest known risk factors for calcium pyrophosphate (CPP) crystal deposition. The pathogenic mechanisms causing CPP crystal formation in…
Abstract Number: 1181 • ACR Convergence 2021
Self Directed Learning Among Internal Medicine Residents: Incorporating a New Teaching Module on Calcium Pyrophosphate Deposition in the Rheumatology Curriculum
Bassel Bou Dargham, Abhishek Nandan, Beth Rubinstein and Stamatina Danielides, Virginia Commonwealth University, Richmond, VA
Background/Purpose: Medical knowledge is evolving at a fast pace, and it is important for medical students and residents to develop self-directed learning skills that will…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].